Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2323

2.

Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.

Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.

Haematologica. 1998 Sep;83(9):791-9.

3.

Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.

Conter V, Schrappe M, Aricó M, Reiter A, Rizzari C, Dördelmann M, Valsecchi MG, Zimmermann M, Ludwig WD, Basso G, Masera G, Riehm H.

J Clin Oncol. 1997 Aug;15(8):2786-91.

PMID:
9256120
4.

Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.

Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.

Klin Padiatr. 1998 Jul-Aug;210(4):192-9.

PMID:
9743952
5.

Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies.

Vecchi V, Aricò M, Basso G, Ceci A, Madon E, Mandelli F, Masera G, Massimo L, Pession A, Zanesco L, et al.

Cancer. 1993 Oct 15;72(8):2517-24.

6.

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.

Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J; Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer.

J Clin Oncol. 2001 Apr 1;19(7):1935-42.

PMID:
11283125
7.

Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

Aricò M, Valsecchi MG, Rizzari C, Barisone E, Biondi A, Casale F, Locatelli F, Lo Nigro L, Luciani M, Messina C, Micalizzi C, Parasole R, Pession A, Santoro N, Testi AM, Silvestri D, Basso G, Masera G, Conter V.

J Clin Oncol. 2008 Jan 10;26(2):283-9. doi: 10.1200/JCO.2007.12.3927.

8.

Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.

Paolucci G, Vecchi V, Favre C, Miniero R, Madon E, Pession A, Rondelli R, De Rossi G, Lo Nigro L, Porta F, Santoro N, Indolfi P, Basso G, Conter V, Aricò M; Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Haematologica. 2001 May;86(5):478-84.

9.

Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.

Nachman J, Sather HN, Cherlow JM, Sensel MG, Gaynon PS, Lukens JN, Wolff L, Trigg ME.

J Clin Oncol. 1998 Mar;16(3):920-30.

PMID:
9508174
11.

Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.

Rizzari C, Valsecchi MG, Aricò M, Conter V, Testi A, Barisone E, Casale F, Lo Nigro L, Rondelli R, Basso G, Santoro N, Masera G; Associazione Italiano Ematologia Oncologia Pediatrica.

J Clin Oncol. 2001 Mar 1;19(5):1297-303.

PMID:
11230471
12.

Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.

Tsurusawa M, Katano N, Yamamoto Y, Hirota T, Koizumi S, Watanabe A, Takeda T, Hatae Y, Yatabe M, Mimaya J, Gushiken T, Nishi K, Anami K, Kikuta A, Kanegane H, Asami K, Nishikawa K, Sekine I, Kawano Y, Iwai A, Furuyama T, Ijichi O, Miyake M, Mugishima H, Fujimoto T, et al.

Med Pediatr Oncol. 1999 Apr;32(4):259-6.

PMID:
10102019
13.
14.

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

Aricò M, Valsecchi MG, Conter V, Rizzari C, Pession A, Messina C, Barisone E, Poggi V, De Rossi G, Locatelli F, Micalizzi MC, Basso G, Masera G.

Blood. 2002 Jul 15;100(2):420-6.

15.

Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.

Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J.

Med Pediatr Oncol. 2001 Jul;37(1):10-9.

PMID:
11466717
16.

Improved outcome for acute lymphoblastic leukemia in children of a developing country: results of the Chilean National Trial PINDA 87.

Campbell M, Salgado C, Quintana J, Becker A, Vargas L, Cabrera ME, Beresi V, Rojas J, Paez E, Tapia S, Zolezzi P, Advis P.

Med Pediatr Oncol. 1999 Aug;33(2):88-94.

PMID:
10398182
17.
18.

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.

Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Uckun FM, Bleyer WA.

Cancer. 1998 Feb 1;82(3):600-12.

PMID:
9452280
19.

Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.

Reiter A, Schrappe M, Ludwig WD, Lampert F, Harbott J, Henze G, Niemeyer CM, Gadner H, Müller-Weihrich S, Ritter J, et al.

Blood. 1992 Nov 15;80(10):2471-8.

20.

Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.

Lo Nigro L, Di Cataldo A, Schiliro G.

Med Pediatr Oncol. 2000 Nov;35(5):449-55.

PMID:
11070476
Items per page

Supplemental Content

Write to the Help Desk